Fig. 3.

BRE expression predicts relapse-free survival in a cohort of 2,324 breast cancer patients. A publicly available database (Kaplan–Meier Plotter [32]) was used to investigate the effect of BRE expression on relapse-free survival (RFS) in a cohort of 2,324 breast cancer patients. Array data (probe set 211566_s_at) of these patients were used to divide patients into two equally sized groups. High BRE expression predicts a favorable prognosis (HR = 0.51, CI = 0.51–0.68, p < 0.001). p-value, HR, and CI were calculated by the logrank method